P50 AG05144/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1988	4
1990	4
1991	2
1992	5
1993	6
1994	4
1995	3
1996	3
1997	1
1998	5
1999	1
2000	1
2001	4
2002	1
2003	4
2005	5
2006	7
2007	6
2008	4
2010	5
2011	1
2012	1
2024	0

1

Neuroimaging through the course of Alzheimer's disease.

Smith CD. Smith CD. J Alzheimers Dis. 2010;19(1):273-90. doi: 10.3233/JAD-2010-1217. J Alzheimers Dis. 2010. PMID: 20061644 Review.

2

A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease.

Schmitt F, Ryan M, Cooper G. Schmitt F, et al. Expert Opin Drug Metab Toxicol. 2007 Feb;3(1):135-41. doi: 10.1517/17425255.3.1.135. Expert Opin Drug Metab Toxicol. 2007. PMID: 17269900 Review.

3

Structural imaging in early pre-states of dementia.

Smith CD. Smith CD. Biochim Biophys Acta. 2012 Mar;1822(3):317-24. doi: 10.1016/j.bbadis.2011.07.002. Epub 2011 Jul 14. Biochim Biophys Acta. 2012. PMID: 21777674 Free PMC article. Review.

4

Neuropathologic substrate of mild cognitive impairment.

Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR. Markesbery WR, et al. Arch Neurol. 2006 Jan;63(1):38-46. doi: 10.1001/archneur.63.1.38. Arch Neurol. 2006. PMID: 16401735

5

Amyloid beta peptide, 4-hydroxynonenal and apoptosis.

Lovell MA, Markesbery WR. Lovell MA, et al. Curr Alzheimer Res. 2006 Sep;3(4):359-64. doi: 10.2174/156720506778249506. Curr Alzheimer Res. 2006. PMID: 17017866 Review.

6

Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.

Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Wang J, et al. J Neurochem. 2005 May;93(4):953-62. doi: 10.1111/j.1471-4159.2005.03053.x. J Neurochem. 2005. PMID: 15857398 Free article.

7

Sudden infant death syndrome: altered aminergic-cholinergic synaptic markers in hypothalamus.

Sparks DL, Hunsaker JC 3rd. Sparks DL, et al. J Child Neurol. 1991 Oct;6(4):335-9. doi: 10.1177/088307389100600409. J Child Neurol. 1991. PMID: 1719064

8

A nonstationary Markov transition model for computing the relative risk of dementia before death.

Yu L, Griffith WS, Tyas SL, Snowdon DA, Kryscio RJ. Yu L, et al. Stat Med. 2010 Mar 15;29(6):639-48. doi: 10.1002/sim.3828. Stat Med. 2010. PMID: 20087848 Free PMC article.

9

Characterization of the immune barrier in human olfactory mucosa.

Mellert TK, Getchell ML, Sparks L, Getchell TV. Mellert TK, et al. Otolaryngol Head Neck Surg. 1992 Feb;106(2):181-8. Otolaryngol Head Neck Surg. 1992. PMID: 1738551

10

Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.

Sparks DL, Hunsaker JC 3rd, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR. Sparks DL, et al. Ann Neurol. 1992 Jun;31(6):611-20. doi: 10.1002/ana.410310608. Ann Neurol. 1992. PMID: 1355334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year